![Xue Feng Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xue Feng Yu
Chief Executive Officer at
CANSINO BIOLOGICS INC.
Net worth: 152 M $ as of 31/07/2026
Profile
Xue Feng Yu founded CanSino Biologics, Inc. He is Chairman, Chief Executive Officer & GM at this company. Dr. Yu received a doctorate from McGill University and an undergraduate degree and a graduate degree from Nankai University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/09/2025 | 35,365,100 ( 26.66% ) | 105 M $ | 31/07/2026 | |
| 31/12/2024 | 6,284,017 ( 9.4% ) | 47 M $ | 31/07/2026 |
Xue Feng Yu active positions
| Companies | Position | Start |
|---|---|---|
| CANSINO BIOLOGICS INC. | Chief Executive Officer | 13/01/2009 |
| SUZHOU RIBO LIFE SCIENCE CO., LTD. | Director/Board Member | 16/07/2020 |
Training of Xue Feng Yu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nankai University
 Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suzhou Ribo Life Science Co., Ltd.
 Suzhou Ribo Life Science Co., Ltd. Pharmaceuticals: GenericHealth Technology Develops siRNA therapeutics for liver, cardiovascular, metabolic and renal diseases | Health Technology |
CanSino Biologics, Inc.
 CanSino Biologics, Inc. BiotechnologyHealth Technology Manufactures and commercializes vaccines | Health Technology |
- Stock Market
- Insiders
- Xue Feng Yu
